Trials / Completed
CompletedNCT02274428
Phase 1 Clinical Trial of PNEUMOSTEM® Treatment in Premature Infants With Intraventricular Hemorrhage
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 23 Weeks – 34 Weeks
- Healthy volunteers
- Not accepted
Summary
Phase 1 clinical trial for the safety and dose determination of Pneumostem (human umbilical cord blood derived mesenchymal stem cells) in the premature infants with intraventricular hemorrhage (IVH, grade 3-4)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pneumostem | human umbilical cord blood derived mesenchymal stem cells |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2016-02-01
- Completion
- 2016-12-01
- First posted
- 2014-10-24
- Last updated
- 2017-04-19
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02274428. Inclusion in this directory is not an endorsement.